- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Methylphenidate Hydrochloride Extended Release Capsule
Total 1204 results
-
Laboratorios Silanes S.A. de C.V.Instituto Mexicano del Seguro SocialCompleted
-
University of CalgaryMultiple Sclerosis Society of CanadaCompleted
-
Endo PharmaceuticalsCompletedPain | Chronic Disease
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Center for Advancing Translational... and other collaboratorsCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Yonsei UniversityCompleted
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States, Canada, Germany, Hungary, Sweden
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States
-
Lorenzo GallonCompletedEnd Stage Renal Disease | Rejection of Renal TransplantUnited States
-
Columbia UniversityVeloxis PharmaceuticalsActive, not recruitingRenal Transplant Rejection | Kidney Transplant Failure and RejectionUnited States
-
University of JohannesburgCompletedEssential HypertensionSouth Africa
-
Sun Yat-sen UniversityWithdrawnRenal Function DisorderChina
-
AbbVie (prior sponsor, Abbott)Completed
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingKnee Osteoarthritis | MetforminBangladesh
-
University of Alabama at BirminghamCompletedRenal Transplant InfectionUnited States
-
Associazione Qol-oneCompletedAcute Myeloid LeukemiaItaly
-
Indivior Inc.CompletedOpioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
GlaxoSmithKlineCompletedAttention Deficit DisorderUnited States
-
Mayo ClinicLindner Center of HOPERecruiting
-
Ensysce BiosciencesPRA Health SciencesCompleted
-
Labopharm Inc.CompletedMajor Depressive DisorderUnited States, Canada
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
VU University of AmsterdamShireCompletedAttention Deficit Hyperactivity DisorderNetherlands
-
Gedeon Richter Plc.Completed
-
Overseas Pharmaceuticals, Ltd.Beijing Capton Pharmaceutical Technology Development Co., LTDNot yet recruiting
-
Oklahoma Medical Research FoundationUniversity of Wisconsin, Madison; University of Oklahoma; National Institute...RecruitingInsulin Resistance | Chronic Disease | Aging | Insulin Sensitivity | MitochondriaUnited States
-
OPKO Health, Inc.CompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Romania, Poland, Mexico, Greece
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Vanderbilt UniversityNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedDiabetes Mellitus | Human Immunodeficiency Virus InfectionUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Endo PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedChronic PainUnited States
-
New York State Psychiatric InstituteCompletedOpioid-use DisorderUnited States
-
Poitiers University HospitalChiesi Farmaceutici S.p.A.TerminatedImmunosuppression | Kidney TransplantFrance
-
GlaxoSmithKlineCompletedRestless Legs SyndromeUnited States, Canada
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedADHD | Attention Deficit Hyperactivity DisorderUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Lee's Pharmaceutical LimitedUnknownAdvanced Hodgkin's Lymphoma
-
Hubei Cancer HospitalRecruiting
-
Dawnrays Pharmaceutical (Holdings) LimitedUnknown
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)Spain, United States, Belgium, Sweden, Australia, Netherlands, United Kingdom, Italy, Austria, Germany, Denmark, France, Norway
-
Alcobra Ltd.CompletedAttention Deficit Hyperactivity DisorderIsrael
-
Walter Reed National Military Medical CenterUnknownPostoperative PainUnited States
-
AstraZenecaCompletedSchizophreniaCanada, Australia, Korea, Republic of, Hong Kong
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States